D.C. Code § 28-4553
Current through codified legislation effective September 18, 2024
It shall be unlawful for any drug manufacturer or licensee thereof, excluding a point of sale retail seller, to sell or supply for sale or impose minimum resale requirements for a patented prescription drug that results in the prescription drug being sold in the District for an excessive price.
D.C. Code § 28-4553